BioCentury | Oct 4, 2018
Emerging Company Profile

Banking on exosomes

...exosomes using immortalized cells, and is already working on methods to scale up its therapies. Tavec Inc....
...LLC, Cambridge, Mass. Massachusetts Institute of Technology, Cambridge, Mass. ReNeuron Group plc (LSE:RENE), Bridgend, U.K. Tavec Inc....
BioCentury | Jun 22, 2017
Targets & Mechanisms

Exosomes deliver

...other companies aim to harness modified exosomes as drug carriers. Four of the companies -- Tavec Inc....
...and the MolecuVax Inc. subsidiary of Therapeutic Solutions International Inc. -- are developing cancer therapies. Tavec...
...Dallas, Texas ReNeuron Group plc (LSE:RENE), Pencoed, U.K. Sorrento Therapeutics Inc. (NASDAQ:SRNE), San Diego, Calif. Tavec Inc....
BioCentury | Feb 1, 2017
Emerging Company Profile

Evoking exosomes

...six other companies are pursuing exosome-based therapeutics, including two 2015 newcos: Codiak BioSciences Inc. and Tavec Inc....
...Mentioned Codiak BioSciences Inc., Cambridge, Mass. Evox Therapeutics Ltd., Oxford, U.K. Karolinska Institute, Stockholm, Sweden Tavec Inc....
...Inc. Evox Therapeutics Ltd. Exotech Bio Inc. Exovita Biosciences Inc. Karolinska Institute Ludwig Maximilians University of Munich Massachusetts General Hospital ReNeuron Group plc Tavec Inc. Therapeutic...
BioCentury | Oct 13, 2016
Strategy

Exosomes in the zone

...2008 Series A $20.00 million May 12, 2010 Series B $60.00 million Jan. 7, 2016 Tavec...
...on exosomes derived from its stem cell lines Benitec Biopharma Ltd. (ASX:BLT; NASDAQ:BNTC) Oct. 2014 Tavec Inc....
Items per page:
1 - 4 of 4
BioCentury | Oct 4, 2018
Emerging Company Profile

Banking on exosomes

...exosomes using immortalized cells, and is already working on methods to scale up its therapies. Tavec Inc....
...LLC, Cambridge, Mass. Massachusetts Institute of Technology, Cambridge, Mass. ReNeuron Group plc (LSE:RENE), Bridgend, U.K. Tavec Inc....
BioCentury | Jun 22, 2017
Targets & Mechanisms

Exosomes deliver

...other companies aim to harness modified exosomes as drug carriers. Four of the companies -- Tavec Inc....
...and the MolecuVax Inc. subsidiary of Therapeutic Solutions International Inc. -- are developing cancer therapies. Tavec...
...Dallas, Texas ReNeuron Group plc (LSE:RENE), Pencoed, U.K. Sorrento Therapeutics Inc. (NASDAQ:SRNE), San Diego, Calif. Tavec Inc....
BioCentury | Feb 1, 2017
Emerging Company Profile

Evoking exosomes

...six other companies are pursuing exosome-based therapeutics, including two 2015 newcos: Codiak BioSciences Inc. and Tavec Inc....
...Mentioned Codiak BioSciences Inc., Cambridge, Mass. Evox Therapeutics Ltd., Oxford, U.K. Karolinska Institute, Stockholm, Sweden Tavec Inc....
...Inc. Evox Therapeutics Ltd. Exotech Bio Inc. Exovita Biosciences Inc. Karolinska Institute Ludwig Maximilians University of Munich Massachusetts General Hospital ReNeuron Group plc Tavec Inc. Therapeutic...
BioCentury | Oct 13, 2016
Strategy

Exosomes in the zone

...2008 Series A $20.00 million May 12, 2010 Series B $60.00 million Jan. 7, 2016 Tavec...
...on exosomes derived from its stem cell lines Benitec Biopharma Ltd. (ASX:BLT; NASDAQ:BNTC) Oct. 2014 Tavec Inc....
Items per page:
1 - 4 of 4